The lawsuit specifically alleges that Glaxo Smith Kline deliberately concealed the significant safety risks associated with the use of Avandia, and continued to promote it as a safe treatment for diabetes despite the known risks of heart attack and disease. What is a third party payor lawsuit? Glaxo Smith Kline marketed Avandia a safer and more effective alternative to the cheaper, existing Type II diabetes medications. In turn, TPPs included Avandia in their formularies and covered Avandia prescriptions at a favorable rate for their members.
According the lawsuits, soon after the FDA approved the drug, concerns began to surface regarding possible heart-related side effects. The lawsuits allege that the study concluded that, compared to competing diabetes drugs, Avandia use was associated with a significant increase in the risk of heart attack.
In February , the U. Senate Finance Committee released a report on Avandia. The plaintiffs are represented by Douglas R.
Plymale and James R. D'Amico Jr. A jury trial is requested. District A. McNamara is assigned to the case. Case No. Sign-up Next time we write about any of these organizations, we'll email you a link to the story. You may edit your settings or unsubscribe at any time. Many consumer health advocate groups question the drug's safety and believe that the FDA should recall the medication. A recent study in British Columbia, Canada, has showed a significant risk of debilitating bone fractures for patients who used the prescription drug.
This study examined the medical history of 84, patients. The study compared the rate of bone fracture for patients who took thiazolidnediones like Avandia and Actos, with patients who took other drugs prescribed for diabetes.
Researchers in the study found that the risk of serious fracture was almost 30 percent for those taking thiazolidnediones like the prescription drug Avandia. Avandia may be prescribed alone or in conjunction with other medications, including metformin, sulfonylureas, or insulin. When it is prescribed along with other drugs, there is an increased risk of low blood sugar.
A lower dose of the other medication may be required to ease the danger. The drug is not recommended for people with active liver disease. It may cause unexpected tiredness, unusually rapid weight gain, dark urine, yellowing of skin, and stomach problems. These symptoms are often associated with liver disease, which is a possible danger of taking Avandia. The British Columbia study showed that older patients are at greater risk of experiencing the dangerous side effects linked to Avandia use.
According to the Avandia website, use of the drug can also increase the risk of becoming pregnant, anemic, or hypoglycemic. On Nov. Food and Drug Administration FDA announced that the manufacturer of Avandia rosiglitazone is adding new information about potential increased risk for heart attacks to the existing boxed warning.
The changes to the labeling are outlined below.
0コメント